People taking GLP-1 drugs were more likely to experience certain types of temporary hair loss within a year of starting treatment, a large new study found. Hair shedding is a known side effect of ...

Americans watching the Super Bowl today will hear a tantalizing pitch: You, too, can live like the rich. All you need is a way to order up health care the way they do. A new ad scheduled to air during ...

The growth potential in the GLP-1 market could help healthcare stocks soar in value. Competition, however, is likely to be fierce. Many drugs offer comparable weight loss. Healthcare companies have ...

With the use of GLP-1 medications on the rise, cardiologists are seeing benefits to heart health, and it might not all be related to weight loss alone. GLP-1 medications, including semaglutide, are a ...

Every time Aditi publishes a story, you’ll get an alert straight to your inbox! Enter your email By clicking “Sign up”, you agree to receive emails from ...

Hims & Hers Health, Inc. is facing increasing regulatory pressure regarding its compounded GLP-1 offering. The GLP-1 revenue stream has been significant for HIMS, but not the only source of growth.

McDonald’s signaled this week it’s looking to better cater to customers on weight-loss drugs — and the name of the game is protein. During a Wednesday earnings call, McDonald’s CEO Chris Kempczinski ...

It’s worth the weight — loss, that is. Despite their blockbuster popularity, GLP-1 medications come with a handful of side effects, mainly along the lines of gastrointestinal issues like nausea and ...

Serena Williams' Super Bowl commercial, which was an ad promoting GLP-1 weight loss drugs and the telehealth company Ro, has been met with criticism online after it aired on Sunday. Williams said in ...

GLP-1 weight-loss drugs are now the focus of a heated legal battle, with a leading drugmaker warning that copycat versions pose a risk to patient safety. "When you go and try to source raw materials ...

Appetite suppression in people taking GLP-1s could lead to deficiencies in vitamins and nutrients, an expert warns Cara Lynn Shultz is a writer-reporter at PEOPLE. Her work has previously appeared in ...

FDA on Friday said it would restrict GLP-1 ingredients Novo, Lilly shares fell after Hims launched the pill on Thursday Hims said the decision followed discussions with stakeholders "Since launching ...